Prostate cancer decisions — 2022

The Board denied an initial compensable disability rating for the service-connected erectile dysfunction, finding that there was no indication of penile deformity and thus not meeting the criteria for a 20% rating under Diagnostic Code 7522.

The Veteran's claims for increased ratings for residuals of prostate cancer prior to April 8, 2021 and erectile dysfunction were denied. The Veteran's diabetes mellitus was rated at 20 percent.,The Veteran's claim for an initial compensable rating for erectile dysfunction was denied as there is no evidence of deformity of the penis. He is in receipt of special monthly compensation (SMC) k due to loss of use of a creative organ.

The Veteran's claims of entitlement to service connection for various conditions have been granted, with the exception that VA treatment records and private medical records are still needed.

The appeal for prostate cancer is dismissed. The Veteran's claim of service connection for an acquired psychiatric disorder, including PTSD, major depressive disorder, and anxiety disorder, is granted.

The Board denied service connection for prostate cancer, t-cell lymphoma, and erectile dysfunction. The Veteran's claims were based on presumed herbicide exposure during service in Thailand, but the evidence did not support such exposure.

The Board has granted service connection for diabetes mellitus, prostate cancer, and chronic lymphocytic leukemia on a presumptive basis due to exposure to herbicide agents during active duty in Thailand. The Veteran's claims for thyroid cancer are remanded.

The Board denied service connection for prostate cancer, diabetes mellitus type II, and peripheral neuropathy of the lower extremities as these conditions are not shown to be related to active service.

Service connection for Parkinson's disease and prostate cancer is granted.,The ED claim has been remanded due to unresolved issues.

The Veteran's bladder cancer is granted service connection as due to exposure to herbicide agents. The appeals for peripheral neuropathy are dismissed.

The Veteran's prostate cancer residuals are rated at 20 percent since December 1, 2018. The discontinuance of the 100% rating for prostate cancer is upheld as it was by operation of law.

The Veteran's prostate cancer is granted service connection based on herbicide exposure in Thailand. His erectile dysfunction, which he claims as secondary to his prostate cancer, is also granted service connection. The Veteran is also granted special monthly compensation for loss of use of a creative organ.

The Board denied service connection for the cause of the Veteran's death due to exposure to ionizing radiation during Operation CROSSROADS, finding that prostate cancer is not a recognized disease associated with such exposure. The evidence did not support a link between the Veteran's in-service radiation exposure and his later-developed prostate cancer.

The Veteran's cause of death was listed as prostate cancer, which the Board found not related to service. The appeal for service connection for the cause of death is denied.

The Veteran's service connection claims for prostate cancer and erectile dysfunction as secondary to prostate cancer or PTSD are granted. The Board finds the Veteran was exposed to herbicides, including Agent Orange, during his service near the Korean DMZ, which entitles him to presumptive service connection for prostate cancer. Erectile dysfunction is also found to be related to the treatment he received for prostate cancer.

The Veteran's appeals for service connection for GERD, hearing loss, and a left hip condition were dismissed due to the Veteran withdrawing his appeal. The claims for hypertension, tinnitus, spinal condition, left lower extremity condition (radiculopathy), prostate cancer, and type 2 diabetes mellitus are remanded.

The Board has remanded the claims for prostate cancer, hypertension, DM, and a kidney condition due to herbicide exposure. The Veteran's reported exposure to Agent Orange is being investigated further.

The Veteran's claims for service connection have been reopened and granted. His bilateral hearing loss disability, tinnitus, diabetes mellitus type II, prostate cancer, ischemic heart disease, right shoulder osteoarthritis with strain, and back disability are all found to be related to his active duty service.

The Veteran's cause of death, metastatic prostate cancer, was not caused or contributed to by his service-connected rheumatic fever. Service connection for the cause of death is denied.

The Board has remanded the cases due to insufficient verification of service at the DMZ during the Veteran's periods of service in Korea. The RO is instructed to make all necessary efforts to verify any herbicide agent exposure, including multiple requests if a limited time period is required.

The Board has determined that the Veteran's prostate cancer is due to asbestos exposure during his active duty service and grants service connection for this condition.